Abstract-Groups of 50 female Swiss mice were fed for 18 months on a standard diet containing sucrose (10 %), sodium cyclamate (5 %) or saccharin (5 %), while 100 control mice were fed on the standard diet alone. The survival times were comparable in all groups and no acute toxic effects were encountered. No local tumours in the gastro-intestinal tract, nor excess incidence of distant tumours, were found in animals fed on the various sweeteners. The mice fed on the diet containing 10 % sucrose gained more weight than animals in the other groups, but did not show an increased incidence of neoplasms.
INTRODUCTION
The two non-caloric synthetic sweeteners that have found wide use as substitutes for dietary sugars are saccharin (2,3-dihydro-3-oxybenzisosulphonazole) and the sodium and calcium salts of cyclamate (N-cyclohexylsulphamate). Until recently saccharin and cyclamate were believed to be relatively inert pharmacologically, and over the wide range of doses that have been studied they produce no acute toxic effects apart from slight softening of the stools (Fitzhugh, Nelson & Frawley, 1951 ; Richards, Taylor, O'Brien & Duescher, 1951 Schoenberger, Rix, Sakamoto, Taylor & Kark, 1953 Taylor, Richards, Wiegand & Weinberg, 1968) . The risks of long-term exposure, however, are still somewhat uncertain. Stein, Serrone & Coulston (1967) saw no haematological, biochemical or pathological changes in monkeys fed sodium cyclamate at 4 g/kg/day for 9 months. In a number of studies no tumours have been reported when cyclamate or its metabolite, cyclohexylamine, have been fed to experimental animals (see Taylor, Richards, Wiegand & Weinberg, 1968 , for review) though a related compound-dicyclohexylamine-has been stated to be weakly carcinogenic to rats (Pliss, 1958; Shabad, 1963 ; Lomonova, 1965) . Previously, Fitzhugh et al. (1951) had observed an "increased incidence of the uncommon condition of abdominal lymphosarcoma" in rats maintained for life on a diet containing 5 % saccharin.
After the present paper had been prepared for publication, we became aware of a report by Bajusz (1969) on the occurrence of myocardial lesions in hamsters given high doses of calcium cyclamate and of the then unpublished observation of an increased risk of neoplasms of the bladder in rats fed on a high concentration of a saccharin-cyclamate mixture (Price, Biava, Oser, Vogin, Steinfeld & Ley, 1970) .
At the time the experiments reported in this paper were begun, the evidence relating to the carcinogenicity of sugars and sweeteners in general was difficult to interpret. This applied particularly to the induction of subcutaneous sarcomas in rats by repeated subcutaneous injections of various sugars, including sucrose (Hueper, 1965; Grasso & Golberg, 1966; Carter, 1970) . Hueper (1965) suggested that such tumours arose because the test carbohydrate was contaminated with polycyclic aromatic hydrocarbons during preparation, while Grasso & Golberg (1966) stressed that non-specific physico-chemical factors such as repeated injection of hypertonic solutions played an important part in sarcoma development. Few, today, would accept that such tumours reflect 'inherent' carcinogenic activity in the sugars themselves. On a more general level, there is some evidence that increased caloric intake per se may favour the development of tumours in experimental animals (Tannenbaum & Silverstone, 1953) . In theory, therefore, the substitution of non-caloric sweeteners such as saccharin and cyclamate for sucrose should lead non-specifically to a reduced risk of neoplasia.
In view of these conflicting observations, it seemed worthwhile to re-appraise the possible carcinogenic activity of cyclamates and other sweeteners added to the diet of experimental animals. In addition to the tests for complete carcinogenic activity, we explored the possibility that the addition of sweetening agents to the diet promoted tumour development after oral treatment with a known carcinogen (benzo[a]pyrene ; BP). The need to examine food additives for co-carcinogenicity as well as for carcinogenicity has been stressed elsewhere (Roe, 1968) but sweetening agents have not, to our knowledge, been tested from this viewpoint.
EXPERIMENTAL

Materials.
The sweetening agents used were sucrose (British Drug Houses Ltd., Poole, Dorset), saccharin (British Saccharin Sales Co. Ltd., Nottingham) and sodium cyclamate (Abbott Laboratories Ltd., Sittingbourne, Kent). BP was obtained from Koch-Light Laboratories, Ltd. (Colnbrook, Bucks.) and polyethylene glycol (PEG) of average molecular weight 400, from British Drug Houses Ltd. (Poole, Dorset).
Animals and diets. Female mice of a random-mated Swiss albino strain (9-14 wk of age) were used. The standard diet used for both control and treated groups was Oxoid Breeding Diet, as supplied by Oxo Ltd. (London). This diet included crude oil (3 .8 %), crude protein (20 . 5 %), crude fibre (2 .6 %), digestible crude oil (3 . 1 %), digestible crude protein (17 .9 %) and digestible crude fibre (1 .2 %). It also contained a mixture of vitamins, including A, B 1 , B2 , B6 , B 12 , D3 , E, nicotinic acid, pantothenic acid, biotin and the 'essential nutritional factors', inositol and choline, and necessary minerals. Test diets were prepared by blending the standard diet and sweeteners in a powdered form in a food mixer. Approximately 5 g dry powdered food, moistened with water, was allocated daily to each mouse, this being rather more than the amount they regularly consumed.
Experimental design and conduct. The mice, divided into eight groups, received various treatments which are summarized in Table 1 gastric instillation of either 0 .2 ml PEG or 50 lig BP in 0 .2 ml PEG after overnight starvation. All mice then received the standard diet only (i.e. without sweeteners) for 7 days, before being transferred to their various test diets. Throughout, water was given ad lib. They remained on these diets until the experiment terminated 18 months after pretreatment with BP or PEG. The mice were weighed fortnightly for the first 4 months of the experiment and monthly thereafter. After the first 6 wk all mice were examined at weekly intervals for obvious tumour development and daily for general health. Sick animals were killed. Postmortem examinations were carried out on mice killed or found dead during the experiment or killed terminally. Some 449 out of 500 mice were so examined ; the remainder were either found in a state of advanced autolysis or had been eaten by cage mates. Post-mortem examination was carried out by a standardized procedure which involved the completion of a form by the entry of negative as well as positive findings (Roe, 1965). All major organs including the urinary bladder but excluding the brain, pituitary gland and spinal cord, were examined macroscopically in the present experiment. All neoplasms, or lesions suspected of being neoplasms, were removed and fixed in Bouin's fluid. Paraffin sections were prepared and stained with haematoxylin and eosin. Because of a misunderstanding, mice were not allocated randomly to the eight treatment groups. The oldest, and therefore heaviest, mice were included mainly in the control groups (groups 1 and 2) while the lightest and youngest mice were allocated to test groups 3-8. In order to see if initial body weight influenced the subsequent incidence of tumours, a distinction was made between heavier (above 36 g) and lighter (below 36 g) animals, designated H and L, respectively, in the two control groups. The observations for these H and L sub-groups are recorded separately in the tables.
RESULTS
Survival
The numbers of survivors at 12, 15 and 18 months are shown in Table 1 . Neither treatment with BP nor subsequent treatment with any of the sweetening agents appeared to 
Body weight
Mice fed on the sucrose diet gained weight faster than mice fed on other diets ( Fig. 1) : at 15 months, sucrose-fed mice weighed on average 4 g more than was to be expected on the basis of their average weight at day 0. A single dose of BP had no effect on the rate of weight gain in mice fed the standard diet (Fig. 2) . Pretreatment with BP did not influence the weight gain in mice fed on diets containing added sucrose or cyclamate but was associated with reduced weight gain in saccharin-fed mice. At the start of treatment the average weight of mice in group 7 was 29 .0 g and of mice in group 8, 28 .9 g; at 6 months, mice in group 7 weighed 41-7 g on average, but those in group 8 only 38 .'7 g; and at 12 months the average weights were 50 . 1 g and 44 . 8 g, respectively. We can think of no logical explanation of this finding and believe it may be spurious.
Neoplasms and hyperplastic changes in the forestomach
• The incidence of forestomach neoplasms in mice that survived for 18 months is given in Table 2 . Clearly, treatment with BP alone increased the incidence of neoplasms arising in the forestomach epithelium. The addition of various sweetening agents did not increase the incidence of such tumours, whether BP was given or not. Focal and more generalized epithelial hyperplasia and hyperkeratosis were seen in some BP-treated mice but the sweetening agents exerted no obvious effect on the incidence or severity of these changes.
Neoplasms at sites other than the forestomach
'the incidence of histologically-confirmed neoplasms, other than those of the forestomach, in animals killed at 18 months is also shown in Table 2 , and of those in animals dying before 18 months, in Table 3 . The incidence of hepatomas was greater in animals treated with BP, but the incidence of pulmonary tumours and malignant lymphomas was similar in all groups. It is noteworthy that none of the treatments appeared to influence tumour incidence in the oesophagus, glandular stomach and small or large intestine. Careful macroscopic examination of the bladder revealed no abnormality in any mouse from any group.
DISCUSSION
The four main findings in this investigation are negative. First, the addition of 10 sucrose, 5 % sodium cyclamate or 5 % saccharin to a standard diet given to female mice was not associated with an increase either in local tumours arising in the gastro-intestinal tract or in distant tumours at other sites. Secondly, none of these sweetening agents showed any co-carcinogenic activity when tested as promoters in mice which had previously received a single oral dose of 50 n BP. Predictably, animals treated with BP alone developed benign and malignant tumours of the forestomach epithelium (Field & Roe, 1965) , but the incidence, number and degree of malignancy of such tumours were not increased in mice fed on any of the sweetening agents. Thirdly, animals on diets containing 10 % sucrose showed a greater rise in body weight than the other groups because of the greater calorific content of the sucrose diet. This rise was independent of pretreatment with BP and was not accompanied by any increase in tumour incidence. The observations by Tannenbaum & Silverstone (1953) , mentioned earlier, might have led to the prediction that tumours would be more common in these groups. Lastly, none of the test agents gave rise to detectable toxic effects and none appeared to have an adverse effect on survival up to 18 months from the start of the experiment.
In spite of the non-random allocation of mice to the various treatment groups, other experience with this strain and consideration of the results as a whole strongly suggest that the three sweetening agents tested possess neither carcinogenic nor tumour-promoting activity under the conditions of the experiment.
Differences between species in susceptibility to cyclamate have not been adequately explored. The need for such work is illustrated by the recent report by Bajusz (1969) which showed that large doses of calcium cyclamate, given orally to hamsters for only 6 days, rapidly induced calcification and necrosis of cardiac and skeletal muscle, coronary sclerosis of the MOnckeberg type and nephrocalcinosis. Equimolecular amounts of calcium given as chloride, aspartate, acetate and ascorbate were inactive. It would seem that the cyclamate part of the calcium cyclamate molecule is necessary for the production of this toxic effect. But at present it appears that the effect is species-specific since calcium cyclamate, given in equivalent doses to rats, did not lead to ectopic calcification. We recorded no evidence of ectopic calcification in the mice of groups 3 and 4.
The findings reported in the present paper are consistent with the view that neither saccharin nor cyclamate are carcinogenic for mice when administered by mouth. This would have been our conclusion had it not been for our becoming aware of the observed increase in the incidence of bladder tumours in rats fed on a sodium cyclamate-sodium saccharin (10:1) mixture in high concentration (Price et al., 1970) and the suspicion that in vivo conversion of cyclamate to cyclohexylamine (Kojima & Ichibagase, 1966; Leahy, Wakefield & Taylor, 1967; Oser, Carson, Vogin Sonders, 1968) was involved in the induction of these tumours. By the time this new information became available, all the mice in our experiment were dead, but Unilever Research Ltd. (Colworth House, Sharnbrook, Bedfordshire) kindly examined mice from our colony of the same strain for ability to convert cyclamate to cyclohexylamine. Four female and eight male mice were fed from the age of 6-8 wk for a period of 2 months on a basic laboratory diet (Spital) and given water containing 0 .5 % sodium cyclamate. Urine from all 12 mice contained cyclohexylamine at a level indicative of a 2-3 % conversion rate.
In view of these later studies, it is likely that mice of groups 3 and 4 in the main experiment also converted some cyclamate to cyclohexylamine. We cannot be sure of this, nor can we exclude the possibility that neoplasms of microscopic dimensions were present in the bladders of the mice of any group. We can, however, with full confidence state that our use of a systematic necropsy regime excludes the possibility that bladder tumours of a size visible to the naked eye were present in any of the 449 mice that were examined post mortem. Bei der Sektion der Mame unter sorgfaltiger wurden makroskopischer Untersuchung keine Neoplasmen der Harnblase gefunden; die Blasen wurden nicht mikroskopisch untersucht.
Es wird daraus der Schluss gezogen, dass unter den beschriebenen Versuchsbedingungen die drei untersuchten Silssstoffe keine carcinogene oder tumorfOrdernde Aktivitat zeigten.
